<DOC>
	<DOC>NCT00611273</DOC>
	<brief_summary>Long term efficacy study of GFX for patients undergoing reduction of glabellar furrowing</brief_summary>
	<brief_title>A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing</brief_title>
	<detailed_description>A Multi-center Long Term Efficacy Trial of GFX for the Reduction of Glabellar Furrowing</detailed_description>
	<criteria>The patient will be included if: Has no medical contraindication Presents for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Class 1 or Higher) Is at least 18 years of age Signs a written informed consent Understands and accepts the obligation to present for scheduled followup visits Understands that the GFX procedure may not be successful Presents at the one month followup visit with an improvement from the base line RNKLS score The patient will be excluded if: Has had an injection of botulinum toxin to the target area within the previous 4 months and still exhibits a positive cosmetic effect to the glabellar frown. Has had silicone, fat, collagen or a synthetic material placed in the glabellar region or surgical correction or excision of the glabellar furrows Has a known bleeding disorder Pregnant Has received or is anticipated to receive antiplatelets, anticoagulants, thrombolytics, or cancer therapy Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled or nasal corticosteroids are acceptable) Has a history of chronic or recurrent infection or compromised immune system Has severe allergies manifested by a history of anaphylaxis Has known lidocaine hypersensitivity Is enrolled in another study Has history of keloid formation The investigator believes the patient is not a suitable candidate for the GFX procedure, or is not likely to receive cosmetic benefitPresents at the one month followup visit with no improvement from the base line RNKLS score</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Glabellar Furrowing</keyword>
</DOC>